Chris Calabrese | LifeSci Advisors, LLC |
Robert J. Gould | President and CEO |
Iain Fraser | Interim Chief Medical Officer |
Edward Tenthoff | Piper Sandler |
Joseph Schwartz | SVB Securities |
Unidentified Analyst | Goldman Sachs |
Matthew Biegler | Oppenheimer |
Judah Frommer | Crédit Suisse |
Good morning and welcome to the Fulcrum Therapeutics First Quarter 2023 Financial Results and Business Update Conference Call. Currently all participants are in a listen-only mode. This call is being webcast live on the Investor Section of Fulcrum’s website at www.fulcrumtx.com and is being recorded.
For opening remarks I would like to introduce Chris Calabrese. Please go ahead.